ClinicalTrials.Veeva

Menu

A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters

Boston Scientific logo

Boston Scientific

Status

Completed

Conditions

Peripheral Vascular Diseases
Thrombosis
Venous Thrombosis

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This registry collects observational data about how mid-length AngioJet catheters (ie XPEEDIOR and DVX models) are used in routine clinical practice.

Full description

The PEARL Registry collects real world data about mid-length AngioJet catheters to:

  • Characterize usage patterns, treatment approaches, and targeted vessels
  • Document treatment strategies, including specific techniques and concomitant therapies
  • Collect outcome data during initial hospitalization and at a 3-month follow-up phone call or visit
  • Evaluate the frequency of specific clinical events in relation to risk factors, diagnosis, and treatments provided
  • Identify treatment strategies that may optimize procedural and clinical outcomes, to facilitate development of treatment guidelines
  • Offer sites a valuable resource for tracking usage and performance of the AngioJet System at their institution

Information collected by the PEARL Registry is intended for educational and clinical research purposes only.

Enrollment

452 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient has been treated with a mid-length AngioJet catheter(defined as 90-120 cm in length)
  • Patient has provided appropriate authorization per institutional policy and procedure.

Exclusion criteria

  • None

Trial design

452 participants in 4 patient groups

Limb Ischemia
Description:
Patients presenting with limb ischemia for treatment
Deep Vein Thrombosis
Description:
Patients presenting with deep vein thrombosis for treatment
Hemodialysis Access
Description:
Patients presenting with thrombosed hemodialysis access for treatment
Other Thrombotic Conditions
Description:
Patients presenting with thrombosed conditions other than limb ischemia, deep vein thrombosis or thrombosed hemodialysis access for treatment.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems